Artelo Biosciences, Inc.
Artelo Biosciences, Inc. (ARTL) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · ARTL · as of Sep 30, 2025
Ownership Breakdown
8
Institutional Holders
$151,661
Total Inst. Value
▼ $68,460 vs Q2
2.33M
Shares Outstanding
freeFloat 91.02%
33,042
13F Shares Held
▲ 16,454 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
ARTL largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
DRW SECURITIES, LLC pharmaceutical preparations | 17.2K | 33.27% | 33.27% | $78.88M | Nov 14, 2025 | NEW |
VANGUARD GROUP INC pharmaceutical preparations | 14.0K | 27.15% | 27.15% | $64.39M | Nov 7, 2025 | NEW |
MORGAN STANLEY pharmaceutical preparations | 1.1K | 2.13% | 2.13% | $5.05M | May 27, 2026 | ▲ 1.1K |
CITIGROUP INC pharmaceutical preparations | 477 | 0.92% | 0.92% | $2.19M | Nov 10, 2025 | ▲ 468 |
UBS GROUP AG pharmaceutical preparations | 209 | 0.40% | 0.40% | $959,000 | Nov 13, 2025 | ▲ 120 |
FMR LLC pharmaceutical preparations | 30 | 0.06% | 0.06% | $138,000 | Nov 13, 2025 | ▲ 29 |
BANK OF AMERICA CORP /DE/ pharmaceutical preparations | 11 | 0.02% | 0.02% | $50,000 | Feb 3, 2026 | ▲ 6 |
ROTHSCHILD INVESTMENT LLC pharmaceutical preparations | 2 | 0.00% | 0.00% | $9,000 | Nov 7, 2025 | NEW |
DANSKE BANK A/S pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Nov 19, 2025 | EXIT |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Nov 12, 2025 | EXIT |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
5
Increased
+1.7K shares3
New Positions
first time holders0
Decreased
−0 shares3
Sold Out
fully exitedNet shares change (top 50)
+1.7K
+1.7K / −0
Net new holders
+5
3 new / 3 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
ARTL insider trading · insider activity
Source: SEC Form 4
29
Buy transactions
40
Sell transactions
0.72
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
MATSUI CONNIE director | Jan 30, 2026 | Award | 292 | $1.71 | $499.32 | 292 | Form 4 ↗ |
Blayney Douglas director | Jan 30, 2026 | Award | 292 | $1.71 | $499.32 | 292 | Form 4 ↗ |
EMANUELE ROBERT MARTIN director | Jan 30, 2026 | Award | 292 | $1.71 | $499.32 | 292 | Form 4 ↗ |
Kelly Steven director | Jan 30, 2026 | Award | 292 | $1.71 | $499.32 | 292 | Form 4 ↗ |
FAVORITO TAMARA A director | Jan 30, 2026 | Award | 292 | $1.71 | $499.32 | 292 | Form 4 ↗ |
Reyes Gregory director | Jan 30, 2026 | Award | 292 | $1.71 | $499.32 | 292 | Form 4 ↗ |
Spring Mark Edward Chief Financial Officer | Jan 29, 2026 | Award | 36,391 | $1.68 | $61.1K | 36.4K | Form 4 ↗ |
Gorgas Gregory D. Pres, CEO, CFO, Treas & Secr | Jan 29, 2026 | Award | 154,713 | $1.68 | $259.9K | 154.7K | Form 4 ↗ |
MATSUI CONNIE director | Oct 28, 2025 | C-Conversion | 70,376 | $3.40 | $239.3K | 70.4K | Form 4 ↗ |
MATSUI CONNIE director | Oct 28, 2025 | C-Conversion | 38,346 | $6.24 | $239.3K | 38.3K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Artelo Biosciences, Inc. (ARTL) is primarily owned by institutional investors, who hold approximately 1.4% of total shares outstanding. Company insiders own approximately 8.98%, while retail and public investors account for the remaining 89.60%.
The largest institutional shareholder of Artelo Biosciences, Inc. is DRW SECURITIES, LLC, holding approximately 17,185 shares — equal to 33.27% of outstanding shares — as of September 30, 2025.
A total of 8 institutional investors currently hold ARTL stock, with a combined institutional value of approximately $151,661 as of the most recent 13F filing period.
Frequently asked questions
ARTL ownershipArtelo Biosciences, Inc. (ARTL) is primarily owned by institutional investors, who hold approximately 1.4% of shares. The largest shareholder is DRW SECURITIES, LLC with a 33.27% stake. Company insiders hold 8.98%. Data sourced from SEC Form 13F as of September 30, 2025.